(Q43616044)

25 November 2017

title

Nonviral gene delivery of erythropoietin by mesenchymal stromal cells (English)

1 reference

25 November 2017

1 reference

5

1 reference

25 November 2017

J Priller

7

0 references

author name string

F Scheibe

1

1 reference

25 November 2017

N Gladow

2

1 reference

25 November 2017

P Mergenthaler

3

1 reference

25 November 2017

A H Tucker

4

1 reference

25 November 2017

D J Prockop

6

1 reference

25 November 2017

publication date

29 September 2011

1 reference

25 November 2017

1 reference

25 November 2017

volume

19

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

550-560

1 reference

Cloning and expression of the human erythropoietin gene

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

The non-haematopoietic biological effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

AAV5-mediated gene transfer to the parotid glands of non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Why are MSCs therapeutic? New data: new insight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Generation of a transplantable erythropoietin-producer derived from human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Virus-based gene therapy strategies for bone regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Therapeutic levels of erythropoietin (EPO) achieved after gene electrotransfer to skin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Duration and level of transgene expression after gene electrotransfer to skin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Disparate host response and donor survival after the transplantation of mesenchymal or neuroectodermal cells to the intact rodent brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Potential risks of bone marrow cell transplantation into infarcted hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Factors influencing the immunogenicity of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Establishment, differentiation, electroporation, viral transduction, and nuclear transfer of bovine and porcine mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Optimization of a gene electrotransfer method for mesenchymal stem cell transfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Highly efficient transfection of human marrow stromal cells by nucleofection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissue-derived stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

7 January 2021

Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

7 January 2021

Non-hematopoietic stem cells as factories for in vivo therapeutic protein production.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

7 January 2021

Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

7 January 2021

Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

7 January 2021

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

7 January 2021

Immunological mechanism underlying the immune response to recombinant human protein therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.139

7 January 2021

Identifiers

DOI

10.1038/GT.2011.139

1 reference

Dimensions Publication ID

25 November 2017

1043652789

0 references

1 reference